Schroder Investment Management Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-522,657
| Closed | -$4.11M | – | 1166 |
|
|
2025
Q1 | $4.11M | Hold |
522,657
| – | – | ﹤0.01% | 802 |
|
|
2024
Q4 | $3.94M | Buy |
522,657
+438,887
| +524% | +$3.3M | ﹤0.01% | 815 |
|
|
2024
Q3 | $638K | Buy |
+83,770
| New | +$638K | ﹤0.01% | 1081 |
|
|
2020
Q1 | – | Sell |
-55,420
| Closed | -$191K | – | 1306 |
|
|
2019
Q4 | $191K | Buy |
+55,420
| New | +$191K | ﹤0.01% | 1166 |
|